Home/Cardiology CME/CE Webinar/Webinar/EMPORIUM – Full Throttle Against HF: From Detection to Protection

EMPORIUM – Full Throttle Against HF: From Detection to Protection

Webinar
Dato’ Dr Azmee Mohd Ghazi
Dato’ Dr Azmee Mohd Ghazi Clinical Director, Heart Failure and Heart Transplant, Institut Jantung Negara (IJN), Malaysia
Dr David Sim
Dr David Sim Cardiologist, Heart Failure Program Director, National Heart Center Singapore; Immediate past president of Heart Failure Society (Singapore)
Dr Joshua Chung
Dr Joshua Chung Cardiology Fellow, Pusat Jantung Sarawak, Malaysia
13 September 2024

Key Takeaways

  • Role of NT-proBNP: a) as a risk predictor for diabetes mellitus; b) to exclude heart failure from dyspnoea, leg swelling or suspected heart failure cases; and c) for prognostication of established heart failure cases
  • SGLT2i has cardioprotective properties
  • If NT-proBNP is elevated in suspected heart failure cases, SGLT2i can be initiated before cardiology consult and echocardiography appointment
Key takeaways

References

  1. Elecsys NT-proBNP v2.0 method sheet.
  2. Roche. Media & Investor Release. Available at: https://assets.roche.com/imported/01_28042021_MR_Cardiac_Claim_Extensions_EN.pdf (accessed June 2024).
  3. O’Rourke et al. 15(6) 461–468 Vascular Medicine 2010
  4. Dzau et al Circulation. 2006;114:2850-2870.
  5. Custodis et al. Journal of Cardiology 62 (2013) 183–187.
  6. ADA Standards of Care. Diabetes Care. 2024;47(Suppl. 1):S179–S218

The information contained in Cardio ThinkLab is intended for healthcare professionals only.
Click "OK" if you are a healthcare professional.

OK

Want to receive the latest updates?